Chinook Therapeutics Inc (KDNY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2019 | 06-2019 | 03-2019 | 12-2018 | 09-2018 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 53,605 | 79,561 | 113,114 | 126,310 | 120,751 |
| Marketable Securities | 178,182 | 172,072 | 153,794 | 140,129 | 145,043 |
| Receivables | 222 | 1,363 | 707 | 12,037 | 17,841 |
| TOTAL | $235,814 | $256,775 | $272,454 | $282,976 | $287,763 |
| Non-Current Assets | |||||
| PPE Net | 25,534 | 26,177 | 28,169 | 29,157 | 29,806 |
| Investments And Advances | 3,593 | 0 | 0 | 11,434 | 12,840 |
| Intangibles | 26,557 | 32,961 | 32,667 | 33,469 | 38,147 |
| Other Non-Current Assets | 21,814 | 22,077 | 22,296 | 468 | 468 |
| TOTAL | $77,498 | $81,215 | $83,132 | $74,528 | $81,261 |
| Total Assets | $313,312 | $337,990 | $355,586 | $357,504 | $369,024 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 1,643 | 1,000 | 1,573 | 1,457 | 780 |
| Accrued Expenses | 13,137 | 11,775 | 10,791 | 13,060 | 12,361 |
| TOTAL | $32,480 | $30,405 | $29,903 | $30,517 | $30,885 |
| Non-Current Liabilities | |||||
| Deferred Revenues | 16,000 | 16,000 | 16,000 | 16,000 | 17,744 |
| Other Non-Current Liabilities | 34,061 | 34,635 | 34,849 | 1,838 | 1,773 |
| TOTAL | $198,786 | $206,535 | $210,294 | $191,676 | $180,444 |
| Total Liabilities | $231,266 | $236,940 | $240,197 | $222,193 | $211,329 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 16,103 | 16,028 | 16,009 | 15,942 | 15,881 |
| Common Shares | 8 | 8 | 8 | 8 | 8 |
| Retained earnings | -467,489 | -446,537 | -427,959 | -404,532 | -378,212 |
| Other shareholders' equity | -178 | 1,042 | 491 | 940 | 1,267 |
| TOTAL | $82,046 | $101,050 | $115,389 | $135,311 | $157,695 |
| Total Liabilities And Equity | $313,312 | $337,990 | $355,586 | $357,504 | $369,024 |